Scientists test new Drug's impact on cholesterol and diabetes meds
NCT ID NCT07222098
Summary
This study aimed to understand how a new drug called calderasib (MK-1084) might change how the body processes two common medications: rosuvastatin (a cholesterol drug) and metformin (a diabetes drug). It involved 16 healthy participants who took the medications with and without calderasib. Researchers measured drug levels in the blood to see if calderasib changed how much of the other drugs stayed in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion ( Site 0001)
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.